Two classes of PREPs are being investigated in this study: nicotine replacement medications intended primarily for use as part of a smoking cessation protocol (e.g., transdermal patch, gum, nasal spray, and inhaler); and low-nitrosamine and/or smokeless oral nicotine delivery systems that do not require the user to expectorate (e.g., nicotine water,
tobacco lozenges,
tobacco packets, Swedish smokeless
tobacco or so-called snus). The analyses for this study will estimate the public health risks and benefits of policies aimed at increasing access to PREPs. The research team will test the feasibility and reliability of a rigorous mathematical model of smoking and nicotine use behavior, as well as develop the computer software to implement this model. The model will produce an unbiased estimate of the net public health effect of increased access to specific PREPs. The method will be applied to data on Swedish snus use that will be obtained from previous research by Foulds and Ramstrom.
Grant Details:
Approved award: $5,450
Awarded on: Sep 2, 2009
Time frame: Oct 1, 2009 - Sep 30, 2010
Grant number: 66624
Grantee:
University of North Carolina at Greensboro
Office of Sponsored Programs, UNCG
1111 Spring Garden Street
P.O. Box 26170
Greensboro, NC 27402-6170
(336) 334-5878
Contact Information:
Joseph V. Terza, Ph.D. (Project Director)
jvterza@uncg.edu
Phone: (336) 334-4892